10/3
04:05 pm
hae
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
Low
Report
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
9/23
11:08 am
hae
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
9/20
01:09 am
hae
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]
Low
Report
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]
9/13
09:02 am
hae
Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.
Medium
Report
Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.
9/11
08:02 am
hae
Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.
9/10
07:59 am
hae
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock.
9/9
10:09 pm
hae
Global Blood Collection Market Size To Worth USD 24.90 Billion By 2033 | CAGR of 8.02% [Yahoo! Finance]
Low
Report
Global Blood Collection Market Size To Worth USD 24.90 Billion By 2033 | CAGR of 8.02% [Yahoo! Finance]
8/28
06:39 pm
hae
Apheresis Market Size to Surge to USD 6.7 Billion by 2034, Driven by Strong Growth Momentum at 7.7% CAGR | Report by Transparency Market Research, Inc. [Yahoo! Finance]
Low
Report
Apheresis Market Size to Surge to USD 6.7 Billion by 2034, Driven by Strong Growth Momentum at 7.7% CAGR | Report by Transparency Market Research, Inc. [Yahoo! Finance]
8/23
10:57 am
hae
Implied Volatility Surging for Haemonetics (HAE) Stock Options [Yahoo! Finance]
Low
Report
Implied Volatility Surging for Haemonetics (HAE) Stock Options [Yahoo! Finance]
8/22
12:33 pm
hae
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Citigroup Inc. from $94.00 to $85.00. They now have a "neutral" rating on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Citigroup Inc. from $94.00 to $85.00. They now have a "neutral" rating on the stock.
8/16
10:49 am
hae
Haemonetics (HAE) Set to Launch VASCADE MVP XL in US [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Set to Launch VASCADE MVP XL in US [Yahoo! Finance]
8/15
06:36 am
hae
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System [Yahoo! Finance]
Low
Report
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System [Yahoo! Finance]
8/15
06:30 am
hae
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System
Low
Report
Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System
8/13
03:14 pm
hae
Haemonetics Co. (NYSE: HAE) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
Low
Report
Haemonetics Co. (NYSE: HAE) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $125.00 price target on the stock.
8/12
09:33 am
hae
Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises [Yahoo! Finance]
Low
Report
Haemonetics (HAE) Q1 Earnings Miss Estimates, Gross Margin Rises [Yahoo! Finance]
8/9
06:12 pm
hae
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $107.00 to $108.00. They now have an "outperform" rating on the stock.
Medium
Report
Haemonetics Co. (NYSE: HAE) had its price target raised by analysts at Barrington Research from $107.00 to $108.00. They now have an "outperform" rating on the stock.
8/9
11:51 am
hae
Is Haemonetics (HAE) Stock Undervalued Right Now? [Yahoo! Finance]
Low
Report
Is Haemonetics (HAE) Stock Undervalued Right Now? [Yahoo! Finance]
8/8
06:00 am
hae
Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
High
Report
Haemonetics 1st Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website